Capricorn prepares for February showdown
The firm’s board continues to push back against opposition among some shareholders to plans for a merger with Israeli independent New Med
The dispute between London-listed Capricorn Energy’s board and shareholders over the proposed merger with Israel’s New Med is likely to come to a head in early February, with an extraordinary general meeting planned for the first of the month. The board expects to hold a “vote on the combination on or around the same date”. The shareholder revolt is being led by London-based fund Palliser Capital, which owns 6.96pc of Capricorn shares but claims that shareholders representing more than 40pc “disapprove of the New Med deal”. The fund called for a general meeting back in December, stating that it, “as required by the articles [of incorporation]... must take place by 30 January 2023 at the late

Also in this section
28 September 2023
Oil minister Oun sends out cautiously optimistic message on oil and gas outlook and says pilot project ready to unlock huge shale reserves key to further growth
27 September 2023
Regional industry body ANGEA remains bullish about Asia's adoption of gas and LNG, despite elevated prices and logistical challenges
26 September 2023
Half a century after the 1973 conflict, the world is dramatically different. But OPEC’s power remains
26 September 2023
Bottlenecks continue to constrain gas-rich Appalachia, and relief may not be in the pipeline